Supplemental Table 3.
Associations between gestational diabetes mellitus, preexisting diabetes mellitus, and body mass index and COVID-19 diagnosis in the INTERCOVID study with a real-time polymerase chain reaction test or an antigen test in the week before or on day of delivery (n=937)
| Variable | n (%) | COVID-19 diagnosis, n (%) | No COVID-19 diagnosis, n (%) | Unadjusted RR (95% CI) | Adjusted RR (95% CI) |
|---|---|---|---|---|---|
| GDM or DM | |||||
| No GDM, no DM | 812 (86.7) | 282 (34.7) | 530 (65.3) | Ref | Ref |
| GDM, no DM | 97 (10.4) | 43 (44.3) | 54 (55.7) | 1.20 (0.94–1.54) | 1.27 (1.01–1.61)a |
| Preexisting DM | 28 (3.0) | 17 (60.7) | 11 (39.3) | 1.64 (1.19–2.25)a | 1.76 (1.29–2.39)a |
| BMI | |||||
| Normal weight (<25 kg/m2) | 562 (60.0) | 182 (32.4) | 380 (67.6) | Ref | Ref |
| Overweight or obese (≥25 kg/m2) | 375 (40.0) | 160 (42.7) | 215 (57.3) | 1.27 (1.07–1.51)a | 1.23 (1.04–1.45)a |
Data were adjusted for maternal age, parity, and tobacco use during pregnancy.
CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; GDM, gestational diabetes mellitus, RR, risk ratio.
Eskenazi et al. COVID-19 and gestational diabetes, diabetes, and body mass index in pregnant women. Am J Obstet Gynecol 2022.
a
P<.05.